Ipsen
Develops and sells medicines in oncology, rare diseases and neuroscience for patients and healthcare professionals
Highlights
- Hiring147 open roles
- New on EvolcAdded 2026-10-29
About Ipsen
Ipsen is a biopharmaceutical company that researches, develops and markets medicines in three therapeutic areas: oncology, rare disease and neuroscience. Products named on its website include Dysport, IQIRVO and Decapeptyl, and in 2026 it announced the acquisitions of Kartos Therapeutics and Memo Therapeutics.
Its customers are patients, caregivers and healthcare professionals. The website states that its products are registered in 88 countries.
The company was founded as a family firm; its origins are Laboratoires Beaufour in Dreux, France, and the Ipsen brand was launched as a subsidiary in 1975. The website describes a workforce of over 5,000 employees. Current job listings cover medical, clinical, R&D, supply chain, sales and IT roles in several countries, including France, the United Kingdom, Germany, Hungary, Romania and Lithuania.
Product: Prescription medicines in oncology, rare disease and neuroscience, including Dysport, IQIRVO and Decapeptyl
Jobs at Ipsen (147)
Ipsen is hiring for 147 roles based in Paris and London. 4 are remote.
Global Medical Customer Experience Lead
New on EvolcSenior MS&T Specialist
New on EvolcGlobal Medical Director Migraine
New on EvolcValue & Access and Public Affairs Lead (w/m/d)
New on EvolcMaintenance Manager
New on EvolcNordic Medical Advisor
New on Evolc
Companies hiring like Ipsen
More biotech & pharma companies
Isomorphic Labs
AI-driven drug discovery platform building predictive and generative models for pharmaceutical research and developmentRemote-friendlyIstesso
Develops oral mitochondrial Complex I modulator medicines to restore tissue repair; lead candidate leramistat is in Phase 2New on EvolcItf Pharma
Rare-disease pharmaceutical company developing treatments for Duchenne muscular dystrophy in the UK and IrelandYoung companyNew on EvolcJanssen-Cilag
Medicines and medical technologies for patients, healthcare professionals and healthcare systemsNew on EvolcSalary transparentKiniksa Pharmaceuticals International, PLC
Biopharmaceutical company developing immune-modulating therapies, focused on cardiovascular diseases such as recurrent pericarditisYoung companyNew on EvolcKinomica
Phosphoproteomic diagnostic platform KScan for cancer treatment-response prediction, for clinicians and drug developersNew on EvolcRemote-friendly
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- AWS
- Google reCAPTCHA
- Matomo
- OneTrust
- WordPress
- nginx